Amgen Inc. (NASDAQ:AMGN) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 9:30 AM ET Company Participants Justin Claeys - Vice President of Investor Relations Jay Bradner - Executive Vice President, Research and Development & Chief Scientific Officer Peter Griffith - Executive Vice President & Chief Financial Officer Conference Call Participants Mohit Bansal - Wells Fargo Mohit Bansal Great. Thank you very much for the third session of the day. My name is Mohit Bansal. I am one of the biopharma ...

Eli Lilly and Company (NYSE:LLY) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 5, 2024 7:45 AM ET Company Participants Jacob Van Naarden - Executive Vice President & President of Lilly Oncology Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn All right. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. Biopharma analyst here at Morgan Stanley. Very pleased to be hosting Eli Lilly this morning. I'm hosting Jake Van Naarden, who is Pr ...

Macy's, Inc. (NYSE:M) Goldman Sachs 31st Annual Global Retailing Conference September 5, 2024 8:15 AM ET Company Participants Tony Spring - Chairman and Chief Executive Officer Adrian Mitchell - Chief Operating Officer and Chief Financial Officer Conference Call Participants Brooke Roach - Goldman Sachs Brooke Roach Good morning, everyone, and welcome to Day Two of our Goldman Sachs Global Retailing Conference. My name is Brooke Roach. I cover the apparel accessories and branded discretionary goods sector h ...

Johnson & Johnson (NYSE:JNJ) Wells Fargo 2024 Healthcare Conference September 5, 2024 11:00 AM ET Company Participants Tim Schmid - Executive Vice President, Worldwide Chairman of MedTech Jessica Moore - Vice President of Investor Relations Tracy Menkowski - Senior Director of Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen Barry, we're ready? All right, good morning. Welcome back. I am Larry Biegelsen, the Medical Device Analyst at Wells Fargo. And it's my plea ...

The Procter & Gamble Company (NYSE:PG) Barclays 17th Annual Global Consumer Staples Conference Call September 5, 2024 8:15 AM ET Company Participants Andre Schulten - Chief Financial Officer John Chevalier - Head, Investor Relations Conference Call Participants Lauren Lieberman - Barclays Lauren Lieberman Okay. All right. Good morning. If everyone can take their seats, we're going to get started. Happy to kick off this morning with P&G. We have the company's CFO, Andre Schulten, with us, and, of course, Joh ...

Woodward (WWD) FY Conference September 05, 2024 11:30 AM ET Speaker0Okay, we'll move right along. Next up, we are delighted to have Woodward today. Today in attendance, we'll have the Director of Investor Relations, Dan Probasnick from Woodward. Woodward is based in Fort Collins, Colorado. It manufactures fuel control systems in highly engineered systems for the aerospace and defense and industrial markets.Woodward has 60,000,000 shares, trades around $162 for almost $10,000,000,000 market cap with $340,000 ...

Corning Incorporated (NYSE:GLW) Citi's 2024 Global TMT Conference September 5, 2024 9:10 AM ET Company Participants Ed Schlesinger - EVP & CFO Conference Call Participants Asiya Merchant - Citi Asiya Merchant My name is Asiya Merchant. I cover the technology, hardware and tech supply chain here at Citi. Welcome to Day 2 of our Global TMT Conference. Very thrilled to have Ed Schlesinger. He's the CFO of Corning. We also have members of the Investor Relations team here in the audience. Of course, this sessio ...

Exxon Mobil Corporation (NYSE:XOM) Barclays 38th Annual CEO Energy-Power Conference Call September 5, 2024 8:00 AM ET Company Participants Dan Ammann - President and Head, Low Carbon Solutions Conference Call Participants Betty Jiang - Barclays Betty Jiang Welcome to the Third Day of the 38th Barclays Annual Energy Conference. It's my great pleasure to introduce and welcome Dan Ammann, President and Head of Low Carbon Solutions at ExxonMobil. This is a business that's going to scale a portfolio of lower emi ...

MetLife, Inc. Conference Call Summary Company Overview - **Company**: MetLife, Inc. (NYSE: MET) - **Participants**: Michel Kalaf (President and CEO), John McCallion (CFO and Head of MetLife Investment Management) Key Industry Insights - **Five-Year Strategy**: MetLife is completing its "Next Horizon" strategy and will introduce a new strategy called "New Frontier" [2][6] - **Market Environment**: The life insurance industry has shifted from historically low interest rates and pandemic challenges to a more stable economy with rebounding interest rates and technological advancements [3][4] - **Demographic Trends**: Population shifts are contributing to renewed growth momentum in the industry [5] Financial Performance Highlights - **Performance Metrics**: MetLife is on track to exceed commitments made during the Next Horizon period, including: - $20 billion in distributable cash [5] - $1 billion in operating leverage for growth and technology [5] - ROE exceeding the target of 13% to 15%, currently at 15.5% [8][10] - Free cash flow targets consistently exceeded [5] New Frontier Strategy - **Growth Focus**: The New Frontier strategy aims to build on the successes of the Next Horizon period, focusing on growth and performance consistency [6][7] - **Business Reshaping**: MetLife has made strategic acquisitions and divestitures to lower risk and enhance growth potential [7] Group Benefits Segment - **Competitive Environment**: The group benefits market is competitive but rational, with a focus on building capabilities beyond pricing [17] - **Growth Strategy**: MetLife targets mid-single-digit premium and fee growth, achieving over $6 billion in PFOs during the Next Horizon period [19][20] - **Customer Complexity**: Employers face increasing complexity in benefits management, presenting opportunities for MetLife to offer comprehensive solutions [21][22] Retirement Income Solutions (RIS) - **Spread Business**: MetLife has seen healthy growth in its spread-based liabilities, with a target growth rate of 2% to 4% annually [33][34] - **Market Opportunities**: The company is focused on jumbo pension risk transfer (PRT) business and structured settlements, with a strong pipeline for growth [35][36] International Markets - **Japan**: MetLife has a strong presence in Japan, with premium income growth exceeding market growth. The company is adapting to currency fluctuations and increasing demand for yen-denominated products [38][39][40][41] - **Latin America**: MetLife is a market leader in LATAM, with significant growth driven by diversification and strong distribution capabilities [42][43][44][46] Commercial Real Estate Portfolio - **Performance**: The commercial mortgage loan portfolio is performing as expected, with a low loan-to-value ratio and manageable charge-off expectations [48][49][50] Capital Management Strategy - **Balanced Approach**: MetLife maintains a balanced approach to capital management, prioritizing organic growth, dividends, buybacks, and strategic M&A opportunities [57][59] Conclusion - MetLife is positioned for continued growth and performance improvement through its strategic initiatives, strong market presence, and focus on customer needs across various segments and regions. The company is optimistic about future opportunities while maintaining a disciplined approach to capital management.

McKesson Corporation (NYSE:MCK) Wells Fargo 2024 Healthcare Conference September 5, 2024 8:45 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Stephen Baxter Good morning. I'm Steve Baxter, the Healthcare Services Analyst at Wells Fargo. We're really pleased to have McKesson with us today. As I'm sure you know, McKesson is the largest drug distributor in the United States, also operates Pharma Services ...